Financial Advocates Investment Management’s Idexx Laboratories IDXX Stock Holding History

Financial Advocates Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-850	Closed	-$456K	–	309
2025 Q2	$456K	Sell	850 -115	-12%	-$55K	0.04%	383
2025 Q1	$405K	Sell	965 -43	-4%	-$18.7K	0.03%	476
2024 Q4	$417K	Buy	1,008 +225	+29%	+$98.7K	0.02%	508
2024 Q3	$396K	Buy	783 +53	+7%	+$25.7K	0.02%	530
2024 Q2	$356K	Buy	730 +245	+51%	+$123K	0.02%	538
2024 Q1	$262K	Hold	485	–	–	0.02%	637
2023 Q4	$269K	Buy	+485	New	+$228K	0.02%	589
2022 Q1	–	Sell	-2,742	Closed	-$1.81M	–	765
2021 Q4	$1.81M	Sell	2,742 -212	-7%	-$133K	0.11%	216
2021 Q3	$1.84M	Buy	+2,954	New	+$1.98M	0.12%	194

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Financial Advocates Investment Management's IDXX Position: Q3 2025 in Review

Financial Advocates Investment Management sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 850 shares — an estimated $456K sold.

Financial Advocates Investment Management first reported a position in IDXX in Q3 2021 and held it in 9 quarters. The position peaked at $1.84M in Q3 2021. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

Financial Advocates Investment Management reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
Financial Advocates Investment Management sold 850 Idexx Laboratories shares in Q3 2025, an estimated $456K.
Financial Advocates Investment Management first reported a position in Idexx Laboratories in Q3 2021 and held it in 9 quarters.
Financial Advocates Investment Management's Idexx Laboratories position peaked at $1.84M in Q3 2021.
1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Financial Advocates Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.